Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
akcea therapeutics
alnylam pharmaceuticals
biopharma
biotech
deals
drugs
duchenne
europe blog main
europe top stories
european medicines agency
fda
harvard pilgrim health care
hereditary transthyretin amyloidosis
inotersen
institute for clinical and economic review
licensing
m&a
muscular dystrophy
new york blog main
new york top stories
onpattro
patisiran
pfizer
roche
san diego blog main
san diego top stories
sarepta therapeutics
tafamidis
What
fda
2
×
gene
2
×
medicine
rna
alnylam
approval
approves
betting
billion
biopharma
cells
deal
drug
duchenne
ema
employ
europe
follows
harmful
historic
hits
interference
make
method
mute
protein
puts
recently
rnai
roche
sarepta
second
swiss
therapeutics
therapy
uses
way
won
Language
unset
Current search:
boston
×
gene
×
fda
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
